IN8bio raises $12.4M in private placement; amends Series A warrants

IN8BIO, INC.

Gross proceeds of ~$12.4M from sale of units at $0.3950 per unit; closing expected Oct 4, 2024.
Units consist of common stock or pre-funded warrants plus Series C warrants (exercise price $0.27, 3-year term).
Series A warrants amended: exercise price reduced from $1.25 to $0.45, term extended by one year from closing.
Company to file resale registration statement within 30 days of closing.
Funds expected to support operating plan into 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.